Company News

  • Targeted drug for the treatment of myelofibrosis: Ruxolitinib

    Targeted pharmacum pro curatione myelofibrosis: Ruxolitinib

    Myelofibrosis (MF) refertur ad myelofibrosis.Morbus etiam rarissimus est.Causa autem eius pathogenesis ignoratur.Typicae manifestationes clinicae sunt cellulae sanguinis juveniles rubrae et anemia granulocytica juvenilis cum magno numero lacrimarum gutta sanguinis rubri cellae...
    Lege plus
  • You should know at least these 3 points about rivaroxaban

    Scias saltem haec 3 puncta circa rivaroxaban .

    Sicut novus oralis anticoagulans, rivaroxaban late adhibitus est in praeventionis et curatione morborum venarum thromboembolicorum et plaga praeventionis in fibrillatione atriali non valvulare.Ut melius rivaroxaban utaris, scias saltem haec 3 puncta....
    Lege plus
  • Changzhou Pharmaceutical received approval to produce Lenalidomide Capsules

    Changzhou pharmaceutica approbavit producere Capsulae Lenalidomide

    Changzhou Pharmaceutical Factory Ltd., subsidiarium Shanghai Pharmaceuticae Holdings, receptaculum medicamenti Registration certificatorium (Certificatum No. 2021S01077, 2021S01078, 2021S01079) a re publica medicamentis Administrationis pro Capsulis Lenalidomide edita (specificatio 5 mg, ...
    Lege plus
  • What are the precautions for rivaroxaban tablets?

    Quae sunt cautiones tabularum rivaroxabanorum?

    Rivaroxaban, quasi novus anticoagulans oralis, late in praeventionis et curatione morborum venarum thromboembolicorum adhibitus est.Quid opus est operam dare cum rivaroxaban accipiendo?Dissimilis warfarin, rivaroxaban non requirit vigilantiam sanguinis concretionis indicae ...
    Lege plus
  • 2021 FDA New Drug Approbationes 1Q-3Q

    Innovatio progressus repellat.Cum ad innovationem venit in evolutione medicamentorum novarum et productorum biologicorum therapeuticorum, FDA centrum est ad medicamentum Aestimationis et Investigationis (CDER) industriam pharmaceuticam omni gradu processus sustinet.Cum intellectu...
    Lege plus
  • Recent developments of Sugammadex Sodium in the wake period of anesthesia

    Recentes progressiones Sugammadex Sodium in sulco periodum anesthesiae

    Sugammadex Sodium novus adversarius est musculorum relaxantium selectivorum non-depolarisantium (myorelaxants), qui primum in hominibus anno 2005 nuntiavit et ex quo in Europa, Civitatibus Foederatis et Iaponia usus est, amet.Comparatus cum medicamentis anticholinesterasis traditis...
    Lege plus
  • Which tumors are thalidomide effective in treating!

    Quae tubera sunt in tractando thalidomide efficax!

    Valet Thalidomide in his tumoribus tractandis!1. In quo solidi tumores thalidomide adhiberi possunt.1.1.pulmonis cancer.1.2.Cancer prostatae.1.3.cancer nodalis rectus.1.4.carcinoma hepatocellulare.1.5.Cancer gastric....
    Lege plus
  • Guangzhou API exhibition in 2021

    Guangzhou API exhibitionem 2021

    LXXXVI Sinarum Internationalis Pharmaceuticae Rudis Materiae/Intermediae/Packaging/Equipmentum Pulchrum (API China brevi) Organizer: Reed Sinopharm Exhibitionis Co., Ltd. Exhibitionis tempus: Maii 26-28, 2021 Venue: Sinarum Import et exportatum Pulchrum Complexum (Guangzhou) Exhibition scale: 60,000 metra quadrata Ex...
    Lege plus
  • Acidum obeticholic

    Die 29 Iunii, Intercept Pharmaceutica nuntiat integram applicationem medicamentorum ab US FDA accepisse de suo FXR agonista obeticholico acido (OCA) pro fibrosi causato a steatohepatitis (NASH) epistulae responsionis non-alcoholicae (CRL).FDA affirmavit in CRL quod in notitia fundatur...
    Lege plus
  • Remdesivir

    Die XXII Octobris Orientalis, US FDA publice approbavit Gilead antiviralem Veklury (remdesivir) usum in adultis 12 annis et maiorem et aestimans saltem 40 kg in hospitalizatione et curatione CoVID-19 egens.Secundum FDA, Veklury nunc solum est FDA probata COVID-19 t...
    Lege plus
  • Approbatio noticia pro Rosuvastatin Calcium

    Nuper, Nantong Chanyoo alterum lapidem in historia fecit!Cum plus uno anno nisus est, primus KDMF Chanyoo ab MFDS approbatus est.Sicut maximus opifex Calcii Rosuvastatin in Sinis, novum capitulum in foro Coreae aperire volumus.Et plura producta b...
    Lege plus
  • Registration Certificate (Rosuvastatin)

    Registration Certificatorium (Rosuvastatin)

    Lege plus
12Next >>> Page 1 / 2